Nieuwkerken, Belgium

Jan Geerinck

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Biotalys. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Geerinck: Innovator in Transgenic Plant Technology

Introduction

Jan Geerinck is a notable inventor based in Nieuwkerken, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic plants. His innovative work focuses on enhancing plant resistance to pathogens, which is crucial for agricultural sustainability.

Latest Patents

Jan Geerinck holds a patent for "Transgenic plants expressing a variable domain of a heavy chain antibody (VHH) that binds to a sphingolipid of a fungus." This patent involves a transgenic plant or plant tissue that includes at least one polynucleotide encoding a polypeptide that specifically binds to a sphingolipid of a fungus. The invention also outlines methods for protecting plants from infections, inhibiting pathogen growth, and increasing pathogen resistance.

Career Highlights

Throughout his career, Jan Geerinck has worked with various companies, including Biotalys and Biotalys NV. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in agricultural biotechnology.

Collaborations

Jan has collaborated with notable professionals in his field, including Peter Verheesen and João Filipe Veloso Vieira. These collaborations have further enriched his research and development efforts.

Conclusion

Jan Geerinck's work in transgenic plant technology exemplifies the potential of biotechnology to address agricultural challenges. His innovative patent and career achievements highlight his commitment to enhancing plant resistance and improving crop health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…